#licensing deal
Related Stories (2)
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026DOJ probes Nvidia's licensing deal with AI startup Groq, NYT reports - Reuters
DOJ probes Nvidia's licensing deal with AI startup Groq, NYT reports Reuters
September 10, 2026